ARTVArtiva Biotherapeutics, Inc.

Healthcare
$6.81+135% 1Y

The financials

Artiva Biotherapeutics, Inc. by the numbers

For the full year FY2025, revenue was $0 (−100% year on year) and net income −$84M. The next results filing is expected around Nov 11, 2026, the same week as a year ago.

Artiva Biotherapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$27M−$23Mn/a
Net income−$25M−$21Mn/a
Diluted EPS−$0.63−$0.87n/a

Biotechnology

The closest names by size in the same industry

Compare peers
RLMD-2.9%
RELMADA THERAPEUTICS, INC.
OCGN-1.8%
Ocugen, Inc.
SRZN+12%
Surrozen, Inc./DE
TTRX-5.0%
Turn Therapeutics Inc.
OBIO+0.88%
Orchestra BioMed Holdings, Inc.
CABA-2.0%
Cabaletta Bio, Inc.